Y-90 Radioembolization (Selective Internal Radiation Therapy)

Radioactive microspheres delivered via catheter to liver tumors. Outpatient or short-stay.

Mild fatigue, nausea; most resume normal activities in 1 week.

Patients with primary or metastatic liver cancer, including those awaiting transplant or surgery.

Targeted internal radiation, preserves healthy liver, tumor shrinkage in 70–90%.

Fatigue, nausea, rare liver toxicity, radiation gastritis.

Surgery or external radiation; Y-90 is less invasive and preserves liver function.